derma2go is a teledermatology provider from Switzerland that connects patients with leading experts from renowned university hospitals and practices. Together with a team of professors, leading dermatologists and university hospitals, derma2go provides patients with high-quality online advice on skin conditions, creating access to world-class dermatological expertise without wasting valuable time in a waiting room.
Overview
Mentions in press and media 11
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jun 19, 2023 | TechTour Growth Health showcases Swiss health solutions | |
| Jan 3, 2023 | Frisches Geld für Online-Dermatologie-Anbieter derma2go | |
| Oct 21, 2021 | Growing together with partners | |
| Aug 24, 2020 | Exponentielles Wachstum bei Derma2go | |
| Aug 24, 2020 | Exponentielles Wachstum bei Derma2go | Derma2go hat eine Finanzierungsrunde in unbekannter Höhe abgeschlossen. Das generierte Kapital wird nun in den weiteren Teamausbau und die Umsetzung vielversprechender Projekte investiert. Damit kann der Wachstumskurs weitergeführt werden. ... |
| Mar 23, 2020 | Startups continue to thrive despite the crisis | |
| Mar 23, 2020 | Startups continue to thrive despite the crisis | The current economic and social state is transforming how business is done. More online models have come in the spotlight, which has opened several opportunities for some of the startups that have been leveraging technology to make life eas... |
| Dec 3, 2019 | Derma2go kooperiert mit Uni Basel | |
| Oct 29, 2018 | Scewo wins IFASinnovation Challenge |
Reviews 0
FAQ about derma2go
When was derma2go founded?
derma2go was founded in 2018.
What has the press written about derma2go?
Parsers VC has collected 11 articles mentioning derma2go, among them “TechTour Growth Health showcases Swiss health solutions” (Jun 19, 2023) and “Frisches Geld für Online-Dermatologie-Anbieter derma2go” (Jan 3, 2023).
Is derma2go still active?
Yes, derma2go is active; its latest activity on Parsers VC dates from Jan 17, 2025.